- Associated Press - Friday, November 6, 2020

LEXINGTON, Ky. (AP) - The University of Kentucky along with two Kentucky hospitals will conduct a clinical trial for a potential COVID-19 vaccine.

UK will partner with Baptist Health Lexington and Norton Healthcare in Louisville for Janssen Pharmaceutical Companies of Johnson & Johnson’s phase three clinical study. The study will evaluate Janssen’s COVID-19 vaccine candidate.

A university press release says the clinical trial for the potential vaccine will require about 60,000 people, including “significant representation” from people 60 and older.

The Kentucky research teams plan to enroll at least 2,000 local volunteers for the trial.

To learn more about the trial and participation, go to StopCOVIDKy.com.



Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2021 The Washington Times, LLC.

Please read our comment policy before commenting.

 

Click to Read More and View Comments

Click to Hide